Medtronic has agreed to be the exclusive U.S. distributor of Contego Medical’s portfolio, which includes devices that provide revascularization treatment for carotid and peripheral vascular disease.

Medtronic’s Percept PC neurostimulator with BrainSense technology [Image courtesy of Medtronic] Medtronic (NYSE: MDT) + announced today that it received CE mark approval for its BrainSense ...

Medtronic India Pvt. Ltd. began operations in India in 1979. It is the wholly owned subsidiary of Medtronic Plc, an American Irish medical devices company. The company has presence across India in ...

Medtronic (NYSE: MDT) + announced today that it entered into an exclusive U.S. distribution agreement with Contego Medical. Under the agreement, Medtronic serves as the sole U.S. distributor for ...

SAN FRANCISCO—While deep-brain stimulation therapy has been available for people with Parkinson’s disease for decades, Medtronic has now received a European approval for what it describes as ...

Shares of Medtronic (NYSE: MDT) are off to a fantastic start in 2025, already rising by 13% year to date. The medical devices giant had some weakness in recent years amid disappointing trends from ...

Analyst Travis Steed of Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), retaining the price target of $100.00. Discover outperforming stocks and invest ...

At the 43rd annual J.P. Morgan Healthcare Conference on Monday, Medtronic CEO Geoff Martha mixed in some breaking news with his usual pitch to investors. Just hours earlier, the Centers for ...

Martha described Medtronic’s new Simplera Sync sensor as “half the size and much easier to apply than our previous sensor,” and said there are more sensors in the pipeline, as well as next-generation ...

Shares of Medtronic are benefiting from an improved earnings growth outlook. The company is capturing strong demand for its new lineup of high-tech medical devices. The stock trades at just 16 ...